cardiovascular risk Archives - Cardiovascular News

Phase III Novartis study shows canakinumab reduces cardiovascular risk in heart attack survivors

26th June 2017

Novartis has announced to...

Write to us
Editorial: Will Date will@bibamedical.com
Advertising: Hannah Shiels hannah@bibamedical.com

BIBA Medical, Europe
526 Fulham Road, Fulham, London, SW6 5NR
TEL: +44 (0)20 7736 8788
Email: info@bibamedical.com

Terms and Conditions | Privacy Policy